Market Snapshot

S&P Futures
4,402.75
Dow Futures
34,760.00
NASDAQ Futures
15,095.25

15.27$-0.81 -5.04%
pre market     22:13:33 pm   
From: To:

Stock Snapshot

16.08
Prev. Close
17.23
Open
63.98M
Market Cap
26240.00
Number of Shares
16.79
Day Low
17.49
Day High
15.27
-
P/E Ratio
3.89M
Free Float in %
-0.73
EPS 2021
7.94
Book Value per Share
11.46
Cash Flow per Share
Opiant Pharmaceuticals, Inc. (OPNT)
Opiant Pharmaceuticals, Inc. (OPNT) stock rallied over -5.04% intraday to trade at $15.27 per share on NASDAQ. The stock opened with a gain of 7.15% at $17.23 and touched an intraday high of $17.49, rising 8.77% against the last close of $16.08. The stock went to a low of $16.79 during the session.

Historical Prices

DateOpenCloseAdj. CloseDaily HighDaily LowVolume
2021-06-30$13.93$13.37$13.37$13.96$13.2732,610
2021-06-29$13.84$13.74$13.74$13.86$13.356,900
2021-06-28$13.10$13.41$13.41$13.68$13.0513,500
2021-06-25$13.60$13.02$13.02$14.10$13.0232,800
2021-06-24$14.20$13.72$13.72$14.20$13.4130,600
2021-06-23$13.93$13.88$13.88$14.10$13.809,200
2021-06-22$13.95$14.19$14.19$14.32$13.5049,800
2021-06-21$13.69$13.87$13.87$13.90$13.6113,500
2021-06-18$13.72$13.90$13.90$13.90$13.2311,500
2021-06-17$13.29$13.82$13.82$13.88$13.2225,900
2021-06-16$13.47$13.55$13.55$13.82$12.7414,200
Opiant Pharmaceuticals, Inc.
233 Wilshirre Boulevard
Suite 280
Santa Monica, CA 90401
United States

http://www.opiant.com
310 598 5410
Employees
30
Sector
Healthcare
Sales or Revenue
Industry
Biotechnology
5Y Sales Change
24.50
Fiscal Year Ends
2020-12-30
Dr. Roger Crystal
Pres, CEO & Director
Mr. David D. O'Toole
Chief Financial Officer
Dr. Phil Skolnick
Chief Scientific Officer
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam